Growth in
the dental bone graft substitute market is driven primarily by the increasing
prevalence of dental disorders, continuous product commercialization, market
availability & product affordability, rising number of geriatric
population, and growing public awareness related to preventive care are driving
the growth of the dental bone graft substitute market.
According to the Latest Research by MarketsandMarkets “The global dental
bone graft substitute market size is projected to reach USD 659 million by
2025 from USD 450 million in 2020, at a CAGR of 7.9% during the forecast period.”
Market Growth Opportunities:
1. Increasing demand from customers
and rising inclination toward cosmetic dentistry
2. Low penetration rates for dental implants
3. Growing demand for bone graft substitutes from emerging markets
4. Changing demographics
Market Size Estimation:
The study involved four major activities to estimate the current size of
the dental bone graft substitute market. Exhaustive secondary research was
carried out to collect information on the market and its different subsegments.
Both top-down and bottom-up approaches were used to estimate and validate the
total size of the dental bone graft substitute market. These methods were also
used extensively to estimate the size of various subsegments in the market. The
research methodology used to estimate the market size includes the following:
1. The key players in the industry and markets have been identified through
extensive secondary research.
2. The industry’s supply chain and market size, in terms of value, have been
determined through primary and secondary research.
3. All percentage shares, splits, and breakdowns have been determined using
secondary sources and verified through primary sources.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=159678690
By type, synthetic bone graft segment is expected to grow at the highest CAGR
during the forecast period
Increasing
technological advancements have increased the number of synthetic graft
options. The benefits of synthetic grafts include availability, sterility, and
reduced morbidity. Also, the synthetic bone grafts have a longer shelf life and
there is no risk of any disease to get transferred. Because of these benefits
synthetic bone graft is the fastest growing type in the dental bone graft
substitutes market.
The
synthetic bone graft segment is expected to account for the 22.0% share of the
global dental bone graft substitutes market in 2019. IngeniOs from Zimmer
Biomet Holdings, Inc. (US) and MASTERGRAFT from BioHorizons IPH, Inc. (US) are
some commonly used synthetic bone grafts.
Europe is the largest regional market for Dental bone graft substitute
Europe is one of the major revenue-generating regions in the dental bone graft
substitute market. The favorable reimbursement & insurance coverage for
major procedures and supportive government regulations for product
commercialization are the major factors driving the growth of the dental bone
graft substitute market in Europe.
Recent Developments:
1. In 2019, Straumann and Modern Dental Group Limited (Hong Kong) entered a
joint venture to create distribution company that will serve the dental
communities in Hong Kong and Macau; Peak Dental Solutions Hong Kong Ltd
2. In 2018, Dentsply acquired OraMetrix, a leading industry provider of
innovative 3-D technology solutions improving the quality and efficiency of
orthodontic care.
3. In 2018, Straumann acquired 30% stake in Botiss biomaterials.
4. In 2017, Straumann acquired 70% stake of its distributor Batigroup for
taking over direct distribution of its products in Turkey.
Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=159678690
Key Players:
Dentsply Sirona (US), Johnson & Johnson (US), Danaher Corporation (US),
Medtronic (Ireland), Strauman (US), Zimmer Dental (US), Geistlich Pharm
(Switzerland), RTI Surgical (US), BioHorizons, IPH, Inc (US), Dentium (South
Korea), LifeSciences Corporation (US), Smith & Nephew (UK), Novabone LLC
(US), Botiss biomaterials GmbH (US), Collagen Matrix Inc. (US), Osteogenics
Biomedical (US), LifeNet Health (US), Wright Medical (US), and Stryker
Corporation (US).
Danaher is one of the leaders in designing, manufacturing, and marketing
innovative products and services to professional, medical, industrial, and
commercial customers. The company holds a significant share in the global
dental bone graft substitute market. To maintain its market position and ensure
future growth, the company adopts organic and inorganic growth strategies.
